IDEXX Laboratories Inc/ US45168D1046 /
2024-07-29 10:00:00 PM | Chg. +2.9200 | Volume | Bid1:57:47 AM | Ask1:57:47 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
472.6300USD | +0.62% | 763,194 Turnover: 181.1 mill. |
470.0000Bid Size: 200 | 475.0000Ask Size: 100 | 39.03 bill.USD | - | 46.47 |
Fundamentals
FY 2023 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 10.17 USD | 25.25% |
EPS Diluted: | 10.06 USD | 25.28% |
Revenues per Share: | 44.06 USD | 8.48% |
Book Value per Share: | 17.87 USD | 143.32% |
Cash Flow per Share: | 10.91 USD | 66.58% |
Dividend per Share: | - USD | - |
Total | in mill. | |
Revenues: | 3,660.95 USD | 8.72% |
Net Income: | 845.04 USD | 24.44% |
Operating Cash Flow: | 906.51 USD | - |
Cash and Cash Equivalents: | 453.93 USD | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | 46.47 | 54.58 |
P/S Ratio: | 10.73 | 12.60 |
P/BV ratio: | 26.45 | 31.07 |
P/CF Ratio: | 43.32 | 50.88 |
PEG: | 1.84 | 2.16 |
Earnings Yield: | 2.15% | 1.83% |
Dividend Yield: | - | - |
Market Capitalization | ||
Market Capitalization: | 39.03 bill. USD | 46.12 bill. USD |
Free Float Market Cap.: | - USD | - USD |
Market Cap. / Employee: | - USD | - USD |
Shares Outstanding: | 82.59 mill. |
Profitability
Gross Profit Margin: | 59.82% |
EBIT Margin: | 29.97% |
Net Profit Margin: | 23.08% |
Return on Equity: | 56.92% |
Return on Assets: | 25.92% |
Financial Strength
Liquidity I / Cash Ratio: | 47.70% |
Liquidity II / Quick Ratio: | 95.78% |
Liquidity III / Current Ratio: | 157.14% |
Debt / Equity Ratio: | 119.59% |
Dynam. Debt / Equity Ratio: | 195.85% |
Efficiency
Employees: | - |
Personal Expenses / Employee: | - USD |
Revenues / Employee: | - USD |
Net Income / Employee: | - USD |
Total Assets / Employee: | - USD |
* Fiscal Year End: | 2023-12-31 |
Accounting Standard: | US GAAP |
Currency: | USD |